Published in Arch Toxicol on March 30, 2013
Multidimensional in vivo hazard assessment using zebrafish. Toxicol Sci (2013) 1.41
Thyroid endocrine disruption in zebrafish larvae after exposure to mono-(2-ethylhexyl) phthalate (MEHP). PLoS One (2014) 0.85
High-throughput RNA sequencing reveals the effects of 2,2',4,4' -tetrabromodiphenyl ether on retina and bone development of zebrafish larvae. BMC Genomics (2015) 0.80
Advances in genomics of bony fish. Brief Funct Genomics (2013) 0.78
Extract of Ganoderma formosanum Mycelium as a Highly Potent Tyrosinase Inhibitor. Sci Rep (2016) 0.75
The developmental effects of pentachlorophenol on zebrafish embryos during segmentation: A systematic view. Sci Rep (2016) 0.75
Is inflammatory bowel disease an independent and disease specific risk factor for thromboembolism? Gut (2004) 2.55
Plant nuclear gene knockout reveals a role in plastid division for the homolog of the bacterial cell division protein FtsZ, an ancestral tubulin. Proc Natl Acad Sci U S A (1998) 2.50
Immunodominant CD4+ T-cell epitope within nonstructural protein 3 in acute hepatitis C virus infection. J Virol (1997) 1.98
Mapping of immunodominant CD4+ T lymphocyte epitopes of hepatitis C virus antigens and their relevance during the course of chronic infection. Hepatology (1995) 1.72
Continuous S-(+)-ketamine administration during elective coronary artery bypass graft surgery attenuates pro-inflammatory cytokine response during and after cardiopulmonary bypass. Br J Anaesth (2010) 1.59
Acute and chronic neuroborreliosis with and without CNS involvement: a clinical, MRI, and HLA study of 27 cases. J Neurol (1991) 1.49
Routine molecular genotyping of HLA-B27 in spondyloarthropathies overcomes the obstacles of serological typing and reveals an increased B *2702 frequency in ankylosing spondylitis. J Rheumatol (1997) 1.39
TERT promoter mutations in ocular melanoma distinguish between conjunctival and uveal tumours. Br J Cancer (2013) 1.38
Glucocerebrosidase mutations in 108 neuropathologically confirmed cases of multiple system atrophy. Neurology (2009) 1.26
Skin decontamination by low-temperature atmospheric pressure plasma jet and dielectric barrier discharge plasma. J Hosp Infect (2012) 1.19
A vigorous virus-specific CD4+ T cell response may contribute to the association of HLA-DR13 with viral clearance in hepatitis B. Clin Exp Immunol (1998) 1.19
A leucine-to-proline substitution causes a defective alpha 1-antichymotrypsin allele associated with familial obstructive lung disease. Genomics (1993) 1.15
Minimal T-cell-stimulatory sequences and spectrum of HLA restriction of immunodominant CD4+ T-cell epitopes within hepatitis C virus NS3 and NS4 proteins. J Virol (2005) 1.09
Family and population studies of HLA and coeliac disease in the West of Ireland. Tissue Antigens (1983) 1.08
Salt dependence, kinetic properties and catalytic mechanism of N-formylmethanofuran:tetrahydromethanopterin formyltransferase from the extreme thermophile Methanopyrus kandleri. Eur J Biochem (1992) 1.07
Joint report of the Second International Workshop on Canine Immunogenetics. Transplant Proc (1976) 1.05
[Genetic transmission of HLA dependent disposition for celiac disease]. MMW Munch Med Wochenschr (1980) 1.01
Type I interferons inhibit hepatitis B virus replication and induce hepatocellular gene expression in cultured liver cells. J Infect Dis (1992) 0.99
Mis-sense mutation of alpha 1-antichymotrypsin gene associated with chronic lung disease. Lancet (1992) 0.95
Anergic TH1 clones specific for hepatitis B virus (HBV) core peptides are inhibitory to other HBV core-specific CD4+ T cells in vitro. J Virol (1996) 0.94
Segregation analysis of HL-A antigens and haplotypes in 50 families of patients with coeliac disease. Transplant Proc (1973) 0.94
Results after laparoscopic lysis of adhesions and placement of seprafilm for intractable abdominal pain. Surg Endosc (2002) 0.92
Linkage group HL-A-MLC-BF (properdin factor B). The site of the Bf locus at the immunogenetic linkage group on chromosome 6. Humangenetik (1975) 0.91
The nasal airflow in noses with septal perforation: a model study. ORL J Otorhinolaryngol Relat Spec (2005) 0.89
DR2-negative narcolepsy. Lancet (1986) 0.89
HLA and diseases: involvement of more than one HLA-linked determinant of disease susceptibility. Immunol Rev (1983) 0.88
Hemarthrosis after trauma to the pediatric knee joint: what is the value of magnetic resonance imaging in the diagnostic algorithm? J Pediatr Orthop (2001) 0.88
Management of kidney injuries in children with blunt abdominal trauma. J Pediatr Surg (2000) 0.88
[Prerequisites for a new health care model for elderly people with multiple morbidities: results and conclusions from 3 years of research in the PRISCUS consortium]. Z Gerontol Geriatr (2011) 0.88
[Anaesthetic-related complications of caesarean section]. Zentralbl Gynakol (2005) 0.85
Initial experience with the stretta procedure for the treatment of gastroesophageal reflux disease. J Laparoendosc Adv Surg Tech A (2001) 0.85
Genetic differences between the salt-wasting, simple virilizing, and nonclassical types of congenital adrenal hyperplasia. J Clin Endocrinol Metab (1985) 0.84
Systemic lupus erythematosus in hereditary deficiency of the fourth component of complement. J Am Acad Dermatol (1982) 0.84
[Psychological distress associated with acute tinnitus]. HNO (2004) 0.84
Sequence polymorphism in the HLA-B promoter region. Immunogenetics (1995) 0.83
Physical interaction of apoptosis-inducing factor with DNA and RNA. Oncogene (2006) 0.83
Rheumatoid nodules without rheumatoid arthritis. Rheumatol Int (1982) 0.81
Subtypes of HLA-DRB1*03, *08, *11, *12, *13 and *14 in early onset pauciarticular juvenile chronic arthritis (EOPA) with and without iridocyclitis. Clin Exp Rheumatol (1994) 0.81
Graft-versus-host disease (GVHD) following marrow grafts from DLA-matched canine littermates. Transplant Proc (1979) 0.81
Population genetics of the MLC response: typing for MLC determinants using homozygous and heterozygous reference cells. Transplant Proc (1973) 0.81
Comparison of S-(+)-ketamine- with sufentanil-based anaesthesia for elective coronary artery bypass graft surgery: effect on troponin T levels. Br J Anaesth (2008) 0.81
Influence of HLA alleles on outcome of hepatitis C virus infection. Lancet (2000) 0.81
Impaired natural killer cell function in hemophiliacs with or without continuous substitution. Blut (1984) 0.80
Different gene defects in the salt-wasting (SW), simple virilizing (SV), and nonclassical (NC) types of congenital adrenal hyperplasia (CAH). Ann N Y Acad Sci (1985) 0.80
Extrinsic allergic alveolitis combined with celiac disease in childhood. Respiration (1982) 0.80
Association of progressive systemic scleroderma to several HLA-B and HLA-DR alleles. Arch Dermatol (1987) 0.80
Sequence analysis of the cystic fibrosis gene in patients with disseminated bronchiectatic lung disease. Application in the identification of a cystic fibrosis patient with atypical clinical course. Klin Wochenschr (1991) 0.80
Subcutaneous curettage vs. injection of botulinum toxin A for treatment of axillary hyperhidrosis. J Eur Acad Dermatol Venereol (2001) 0.79
Characterization of DR blank alleles by restriction fragment length polymorphism (RFLP). Tissue Antigens (1987) 0.79
HLA--D typing in 72 psoriasis vulgaris patients: distribution of seven HLA--D alleles. Tissue Antigens (1978) 0.78
HLA antigens in alopecia areata. Arch Dermatol (1977) 0.78
Canine marrow grafts in donor-recipient combinations with one-way nonstimulation in mixed lymphocyte culture. Transplant Proc (1975) 0.78
University postgraduate training in implant dentistry for the general dental practitioner. Aust Dent J (2010) 0.78
University teaching of implant dentistry: guidelines for education of dental undergraduate students and general dental practitioners. An Australian consensus document. Aust Dent J (2010) 0.78
HLA family studies in patients with atopic dermatitis. Monogr Allergy (1977) 0.78
HLA-A, -B, and -D antigens in paralytic poliomyelitis. Tissue Antigens (1979) 0.77
Antilymphocytic antibodies and marrow transplantation. VI. Graft-versus-host tolerance in DLA-incompatible dogs after in vitro treatment of bone marrow with absorbed antithymocyte globulin. Transplantation (1979) 0.77
Pvu II polymorphism in the primate homologue of the mouse B144 (LST-1). A novel marker gene within the tumor necrosis factor region. Hum Immunol (1995) 0.77
Polymorphism of the HLA-C promotor region. Immunogenetics (1997) 0.77
HLA-DR2 correlates with rapid-eye-movement sleep latency in normal human subjects. Lancet (1986) 0.77
Hematopoietic turnover index in reactive and neoplastic bone marrow lesions: quantification by apoptosis and PCNA labeling. Ann Hematol (1997) 0.77
Linkage disequilibria between HLA-B, C1_4_1, MICA and MICB. Tissue Antigens (2001) 0.77
[Effectiveness of oral versus parenteral iron substitution in autologous blood donors]. Infusionsther Transfusionsmed (1994) 0.77
Identification of a new HLA-B7-associated C21-hydroxylase deficiency gene by restriction enzyme length polymorphism. Immunogenetics (1987) 0.77
Influence of HLA compatibility on the incidence of cardiac allograft vasculopathy after heart transplantation. Transplant Proc (1995) 0.77
Nucleotide sequence of a novel HLA-B44 subtype B*4405. Immunogenetics (1994) 0.77
Allelic variation in the TNF-beta gene does not explain the low TNF-beta response in patients with primary biliary cirrhosis. Scand J Immunol (1991) 0.77
Consequences of antigen self-presentation by tumor-specific cytotoxic T cells. Immunobiology (2000) 0.77
[Short-term and long-term complications after transplantation of cultivated limbal epithelium]. Ophthalmologe (2013) 0.77
HLA typing in families with multiple cases of rheumatoid arthritis. Ann Rheum Dis (1991) 0.76
Bone marrow donor routine HLA typing identified a novel B*55 allele, B*5517, confirmed by allele-specific DNA cycle sequencing. Tissue Antigens (2005) 0.76
Juvenile arthritis: genetic update. Baillieres Clin Rheumatol (1998) 0.76
Characteristic pattern and management of intra-articular knee lesions in different pediatric age groups. J Pediatr Orthop (2001) 0.76
Penetration of piperacillin and tazobactam into inflamed soft tissue of patients with diabetic foot infection. Antimicrob Agents Chemother (2005) 0.76
Class I associations and frequencies of class II HLA-DRB alleles by RFLP analysis in children with rheumatoid-factor-negative juvenile chronic arthritis. Rheumatol Int (1993) 0.76
[Systemic lupus erythematosus in hereditary complement 4 deficiency]. Hautarzt (1984) 0.76
[Histocompatibility antigens (HL-A) in psoriasis. A study of 104 unrelated patients (author's transl)]. Dtsch Med Wochenschr (1974) 0.75
Repair of calvarial defects in rats by prefabricated hydroxyapatite cement implants. J Biomed Mater Res A (2004) 0.75
Routine HLA sequence-specific-oligonucleotide typing and confirming sequence-based typing of a prospective bone marrow donor identified a novel B*27 allele, HLA-B*2734. Tissue Antigens (2006) 0.75
HLA haplotypes and glucose tolerance in families of patients with juvenile-onset diabetes mellitus. Lancet (1976) 0.75
Thoughts on the implantation of prosthetic material at the esophageal hiatus in children. Pediatr Surg Int (2003) 0.75
Letter: HL-A antigens in acne conglobata: a negative study. Arch Dermatol (1974) 0.75
A study of the occurrence of HLA DR2 in 124 narcoleptics: clinical aspects. Schweiz Arch Neurol Psychiatr (1988) 0.75
Efficacy of inhaled iloprost in the management of pulmonary hypertension after cardiopulmonary bypass in infants undergoing congenital heart surgery. A case series of 31 patients. HSR Proc Intensive Care Cardiovasc Anesth (2011) 0.75
[Ankylosing spondylitis and the histocompatibility antigen HL-A 27]. Verh Dtsch Ges Inn Med (1974) 0.75
Further population studies of HLA-D alleles in the German population [proceedings]. Z Immunitatsforsch Immunobiol (1976) 0.75
Optical properties of strain-compensated CdSe/ZnSe/(Zn,Mg)Se quantum well microdisks. Opt Express (2015) 0.75
Kidney transplantation following treatment with cyclophosphamide and bone marrow grafting. Transplant Proc (1977) 0.75
Investigations of red cell glyoxalase in recombinant families. Eur J Immunol (1976) 0.75
[Long-term therapy using horse anti-dog lymphocyte globulin without sensitization against horse protein]. Blut (1977) 0.75
B-cell-specific alloantigens in recombinant families. Transplant Proc (1977) 0.75
Representative HL-A phenotype and haplotype frequencies of the german population. Z Immunitatsforsch Exp Klin Immunol (1975) 0.75
[Histocompatibility antigens in rheumatic diseases (proceedings)]. Z Rheumatol (1976) 0.75
HLA-B/D recombination frequency and MLC studies in recombinant families [proceedings]. Z Immunitatsforsch Immunobiol (1976) 0.75
HLA-haplotypes and glucose tolerance in families of patients with juvenile onset diabetes mellitus (JOD) [proceedings]. Diabete Metab (1976) 0.75
[Histocompatibility antigens in rheumatic diseases]. Verh Dtsch Ges Rheumatol (1976) 0.75
[NMR studies of piperidinoacetanilides with pharmacologic activity]. Pharmazie (1976) 0.75
[Proceedings: Ankylosing spondylitis (Ap.a.) and the histocompatibility antigen HL-A 27]. MMW Munch Med Wochenschr (1974) 0.75
HLA family studies in patients with atopic dermatitis [proceedings]. Z Immunitatsforsch Immunobiol (1976) 0.75
Letter: HL-A antigens and psoriasis. N Engl J Med (1974) 0.75